Jun 15, 2023 8:00am EDT bioAffinity Technologies Presents Research Findings at UMass RNA Therapeutics Symposium
Mar 31, 2023 5:52pm EDT bioAffinity Technologies Reports Fourth Quarter and Full Year 2022 Financial Results
Mar 28, 2023 8:00am EDT bioAffinity Technologies Announces Publication of Peer-Reviewed Paper on Proprietary Beads Used in CyPath® Lung for Noninvasive Detection of Early-Stage Lung Cancer
Mar 24, 2023 8:00am EDT bioAffinity Technologies to Report Fourth Quarter 2022 Financial Results on March 31, 2023
Feb 13, 2023 8:00am EST bioAffinity Technologies Appoints Julie Anne Overton Director of Corporate Communications
